Home/Filings/4/0001209191-20-038191
4//SEC Filing

COLUMN GROUP II, LP 4

Accession 0001209191-20-038191

CIK 0001673772other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:31 PM ET

Size

16.6 KB

Accession

0001209191-20-038191

Insider Transaction Report

Form 4
Period: 2020-06-18
Kutzkey Tim
10% OwnerOther
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Ponoi Management, LLC
10% OwnerOther
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
GOEDDEL DAVID V
Director10% Owner
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-18+22,50022,500 total(indirect: See Footnote)
    Exercise: $28.27Exp: 2030-06-17Common Stock (22,500 underlying)
Footnotes (2)
  • [F1]The option shall vest in a series of three successive equal annual installments over the three-year period measured from the date of grant, subject to the continuous service of Peter Svennilson as a director of the Issuer through each applicable vesting date.
  • [F2]The option was granted to Peter Svennilson, a director of the Issuer who is a managing partner of The Column Group II GP, LP ("TCG II GP"), Ponoi Management, LLC ("Ponoi LLC") and Ponoi II Management, LLC ("Ponoi II LLC"), which are the general partners of The Column Group II, LP ("TCG II LP"), Ponoi Capital, LP ("Ponoi LP") and Ponoi Capital II, LP ("Ponoi II LP," and, together with TCG II LP and Ponoi LP, the "Funds"), respectively. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of Ponoi LLC and Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. Under the partnership agreements of the Funds, Mr. Svennilson is deemed to hold the option for the economic benefit of the Funds. The reporting persons may be deemed indirect beneficial owners of the option. The reporting persons disclaim beneficial ownership of the option except to the extent of their pecuniary interest therein.

Issuer

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001600420

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:31 PM ET
Size
16.6 KB